216 related articles for article (PubMed ID: 11860566)
1. Giant cell fibroblastoma in a child misdiagnosed as a dermatofibroma.
Nguyen CM; Burch JM; Fitzpatrick JE; Peterson SL; Weston WL
Pediatr Dermatol; 2002; 19(1):28-32. PubMed ID: 11860566
[TBL] [Abstract][Full Text] [Related]
2. Possible contribution of PDGF-BB-induced autophagy in dermatofibrosarcoma protuberans: Autophagy marker Atg5 could be a differential marker between dermatofibrosarcoma protuberans and dermatofibroma.
Motegi SI; Fujiwara C; Sekiguchi A; Yamazaki S; Yokoyama Y; Yasuda M; Ishikawa O
J Dermatol Sci; 2019 Feb; 93(2):139-141. PubMed ID: 30704939
[No Abstract] [Full Text] [Related]
3. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans.
Wick MR; Ritter JH; Lind AC; Swanson PE
Semin Cutan Med Surg; 1999 Mar; 18(1):91-8. PubMed ID: 10188848
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
Abdaljaleel MY; North JP
Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
[TBL] [Abstract][Full Text] [Related]
5. Atrophic dermatofibroma accompanied by aneurysmatic characteristics.
Curcó N; Pagerols X; García M; Tarroch X; Vives P
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):331-3. PubMed ID: 16503899
[TBL] [Abstract][Full Text] [Related]
6. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report.
Warbrick-Smith J; Hollowood K; Birch J
J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):e785-7. PubMed ID: 20655288
[TBL] [Abstract][Full Text] [Related]
8. Fat necrosis with an associated lymphocytic infiltrate represents a histopathologic clue that distinguishes cellular dermatofibroma from dermatofibrosarcoma protuberans.
Schechter SA; Bresler SC; Patel RM
J Cutan Pathol; 2020 Oct; 47(10):913-916. PubMed ID: 32412128
[TBL] [Abstract][Full Text] [Related]
9. Giant cell fibroblastoma in a 3-year-old boy.
Vargas-Gonzalez R; Solis-Coria A
Pathol Oncol Res; 2003; 9(4):249-51. PubMed ID: 14688833
[TBL] [Abstract][Full Text] [Related]
10. A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.
Brailsford C; Khamdan F; Dirr MA; Sagut P; Nietert PJ; Elston D
J Cutan Pathol; 2024 Apr; 51(4):306-310. PubMed ID: 38124386
[TBL] [Abstract][Full Text] [Related]
11. FNA diagnosis of giant cell fibroblastoma: a case report of an unusual pediatric soft tissue tumor.
Davis JL; Mathes E; Berry AB
Diagn Cytopathol; 2015 Apr; 43(4):325-8. PubMed ID: 25088682
[TBL] [Abstract][Full Text] [Related]
12. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma.
Sandberg AA; Bridge JA
Cancer Genet Cytogenet; 2003 Jan; 140(1):1-12. PubMed ID: 12550751
[No Abstract] [Full Text] [Related]
13. Composite dermatofibrosarcoma protuberans-giant cell fibroblastoma recurring as Bednár tumor-giant cell fibroblastoma with mucoid lakes and with amputation neuroma.
Zámecník M; Michal M; Chlumská A
Cesk Patol; 2002 Oct; 38(4):173-7. PubMed ID: 12629865
[TBL] [Abstract][Full Text] [Related]
14. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report.
El Hachem M; Diociaiuti A; Latella E; Zama M; Lambiase C; Giraldi L; Surrenti T; Callea F
Pediatr Dermatol; 2013; 30(5):e74-7. PubMed ID: 23534369
[TBL] [Abstract][Full Text] [Related]
15. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.
Jha P; Moosavi C; Fanburg-Smith JC
Ann Diagn Pathol; 2007 Apr; 11(2):81-8. PubMed ID: 17349565
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
17. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Zelger BW; Ofner D; Zelger BG
Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
[TBL] [Abstract][Full Text] [Related]
18. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]